Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence

by Bandiera Elisabetta, Romani Chiara, Rossi Elisa, Todeschini Paola, Falchetti Marcella, Donzelli Carla, Tognon Germana, Odicino Franco E, Bignotti Eliana, Ravaggi Antonella, Calza Stefano, Tassi Renata A, Zanotti Laura, Pecorelli Sergio, Santin Alessandro D
Published 2009-07-01

Kinase-driven metabolic signalling as a predictor of response to carboplatin–paclitaxel adjuvant treatment in advanced ovarian cancers

by Sereni, Maria Isabella, Baldelli, Elisa, Gambara, Guido, Ravaggi, Antonella, Hodge, K Alex, Alberts, David S, Guillen-Rodriguez, Jose M, Dong, Ting, Memo, Maurizio, Odicino, Franco, Angioli, Roberto, Liotta, Lance A, Pecorelli, Sergio L, Petricoin, Emanuel F, Pierobon, Mariaelena
Published 2017

Activity of chemotherapy in mucinous ovarian cancer with a recurrence free interval of more than 6 months: results from the SOCRATES retrospective study

by Alletti Desiderio, Breda Enrico, Lauria Rossella, Manzione Luigi, Ghezzi Fabio, Mereu Liliana, Villa Antonella, Katsaros Dionyssios, Cormio Gennaro, Odicino Franco, Scollo Paolo, Scarfone Giovanna, Ferrandina Gabriella, Pignata Sandro, Ballardini Michela, Lombardi Alessandra, Sorio Roberto, Mangili Giorgia, Priolo Domenico, Magni Giovanna, Morabito Alessandro
Published 2008-09-01